Chromosomal CGH identifies patients with a higher risk of relapse in neuroblastoma without MYCN amplification

相似書籍

• Localised and unresectable neuroblastoma in infants: excellent outcome with low-dose primary chemotherapy
  由: Rubie, H, et al.
  出版: (2003)
• Clinical Characteristics and Outcome of Patients with Neuroblastoma Presenting Genomic Amplification of Loci Other than MYCN
  由: Guimier, Anne, et al.
  出版: (2014)
• WT1 expression is inversely correlated with MYCN amplification or expression and associated with poor survival in non‐MYCN‐amplified neuroblastoma
  由: Masserot, Caroline, et al.
  出版: (2015)
• Birth-related characteristics, congenital malformation, maternal reproductive history and neuroblastoma: the ESCALE study (SFCE)
  由: Munzer, Caroline, et al.
  出版: (2008)
• Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study)
  由: Schleiermacher, G, et al.
  出版: (2011)